NEW: FDA is reportedly considering limiting use of Regeneron and Eli Lilly monoclonal, because they are not proven to work against Omicron. That would be a HUGE upheaval in Florida - which has opened dozens of disruption sites for those monoclonals & touted their availability.
3
2
3
0
0
Comes after NIH already updated its guidance, recommending AGAINST using the Eli Lilly and Regeneron drugs. Adds the monoclonal Sotrovimab is still effective. But supplies are limited.
@jayobtv Gotta love the brilliance of not allowing treatment...